• FirefoxTry Yahoo Finance on Firefox »
  •  Dow Down0.23% Nasdaq Down0.63%

    Aradigm Corporation (ARDM)

    -NasdaqCM
    6.92 Down 0.27(3.69%) 3:11PM EDT
    Add to Portfolio
    ProfileGet Profile for:
    Aradigm Corporation
    3929 Point Eden Way
    Hayward, CA 94545
    United States - Map
    Phone: 510-265-9000
    Fax: 510-265-8878
    Website: http://www.aradigm.com

    Details 
    Index Membership:N/A
    Sector:Healthcare
    Industry:Drug Delivery
    Full Time Employees:18

    Business Summary 

    Aradigm Corporation, a specialty pharmaceutical company, focuses on the development and commercialization of drugs delivered by inhalation for the prevention and treatment of severe respiratory diseases. Its lead development candidates are proprietary formulations of the potent antibiotic ciprofloxacin (Pulmaquin (ARD-3150) and Lipoquin (ARD-3100)) that are delivered by inhalation for the management of infections associated with severe respiratory diseases, such as non-cystic fibrosis bronchiectasis (BE) and cystic fibrosis (CF). The company is conducting Phase 3 clinical trials with Pulmaquin in BE; Phase 2b trial with Lipoquin and Pulmaquin in BE. It has also completed a Phase 2a trial with Lipoquin in CF and Phase 2a trial with Lipoquin in BE. The company’s proprietary program under development comprises ARD-1600 Inhaled Nicotine, a smoking cessation therapy. The company has collaboration agreements with Oregon State University and Grifols, S.A. Aradigm Corporation was founded in 1991 and is headquartered in Hayward, California.

    Key Statistics


    Company Websites 
    Home Page
    Search Yahoo! for:
    More on Aradigm Corporation

    Key Executives 
     PayExercised
    Dr. Igor Gonda Ph.D., 67
    Chief Exec. Officer, Pres and Exec. Director
    706.00K0.00
    Ms. Nancy E. Pecota , 55
    Chief Financial Officer, VP of Fin. and Corp. Sec.
    478.00K0.00
    Mr. Juergen Froehlich M.D., MBA, FCPh, 58
    Chief Medical Officer
    501.00K0.00
    Dr. Robert A. Reed Ph.D., 54
    VP of Regulatory & Quality
    N/AN/A
    Amounts are as of Dec 31, 2014 and compensation values are for the last fiscal year ending on that date. Pay is salary, bonuses, etc.Exercised is the value of options exercised during the fiscal year.
    Currency in USD.
    View Insiders